Managing Postmenopausal Osteoporosis: AACE Guideline Updates and What They Mean for Your Patients
The goal of this activity is to inform clinicians of the most recent guideline updates for the management of osteoporosis among postmenopausal women, as well as discuss how to apply guideline recommendations in clinical practice to reduce the risk of fracture among postmenopausal women with osteoporosis.
This activity is intended for endocrinologists, orthopedists & orthopedic surgeons, and primary care physicians.
Upon completion of this activity, participants will:
- Have increased knowledge regarding the
- Latest guideline updates on the management of osteoporosis among postmenopausal women
- Have greater competence related to
- Applying guideline recommendations and the latest treatment advances into clinical practice to reduce the risk of fracture among individuals with osteoporosis
Steven Petak, MD, JD
Associate Clinical Professor
Weill Cornell College
Division Head and Chief
Houston Methodist Hospital
Texas Medical Center
Disclosure: Steven Petak, MD, JD has disclosed the following relevant financial relationships:
Served as a speaker or a member of a speakers bureau for: Alexion; Amgen; Radius Health, Inc.
Rachel Pessah-Pollack, MD, FACE
Clinical Associate Professor
Division of Endocrinology, Diabetes, and Metabolism
NYU Langone Health
New York, New York
Disclosure: Rachel Pessah-Pollack, MD, FACE, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Boehringer Ingelheim; Eli Lilly; Radius Health, Inc.; Sanofi
Served as a speaker or a member of a speakers bureau for: Boehringer Ingelheim; Eli Lilly; Radius Health, Inc.; Sanofi
Jennifer Kelly, DO
Metabolic Bone Program
Vermont Medical Center
Department of Medicine
Division of Endocrinology and Diabetes Larner College of Medicine
University of Vermont
Disclosure: Jennifer Kelly, DO, has disclosed the following relevant financial relationships:
Received grants for clinical research from: Takeda
Karen Badal, MD, MPH
Medical Education Director, Medscape, LLC
Disclosure: Karen Badal, MD, MPH, has disclosed the following relevant financial relationships:
Owns stock, stock options or bonds, from: Kallyope, Inc.
Heather Lewin, MAT
Associate Director, Medscape, LLC
Robert Morris, PharmD
Associate Director, Accreditation and Compliance, Medscape, LLC
Disclosure: Robert Morris, PharmD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: ViiV Healthcare
Owns stock, stock options, or bonds from: GlaxoSmithKline
Learner Bill of Rights
The American Association of Clinical Endocrinologists (AACE) recognizes that you are a lifelong learner who has chosen to engage in continuing medical education to identify or fill a gap in knowledge, skill, or performance. As part of AACE's duty to you as a learner, you have the right to expect that your continuing medical education experience with AACE includes:
Promotes improvements or quality in healthcare;
Is valid, reliable, and accurate;
Offers balanced presentations that are free of commercial bias for or against a product/service;
Is vetted through a process that resolves any conflicts of interests of planners, teachers, or authors;
Is driven and based on learning needs, not commercial interests;
Addresses the stated objectives or purpose; and
Is evaluated for its effectiveness in meeting the identified educational need.
A LEARNING ENVIRONMENT that:
Supports learners' ability to meet their individual needs;
Respects and attends to any special needs of the learners;
Respects the diversity of groups of learners; and
Is free of promotional, commercial, and/or sales activities.
Relevant financial relationships planners, teachers, and authors have with commercial interests related to the content of the activity; and
Commercial support (funding or in-kind resources) of the activity.
Declaration of Disclosure and Conflicts of Interest
It is the policy of AACE to ensure balance, independence, objectivity and scientific rigor in all of its CME activities. Presentation content may include discussion of an unlabeled or an investigational use of a product. AACE requires that participating faculty disclose to the audience any product(s) and its use(s) discussed in the educational activity that are unapproved/unlabeled for the use by the FDA or still considered investigational in nature.
Everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships. "Relevant financial relationships" are financial relationships in any amount occurring within the past 12 months that create a conflict of interest. AACE requires speakers, faculty, CME Committee and other individuals who are in a position to control the content of this educational activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly evaluated by AACE for fair balance, scientific objectivity of studies mentioned in the presentation and educational materials used as basis for content, and appropriateness of patient care recommendations.
The intent of this disclosure is not to prevent a speaker with commercial affiliations from presenting, but rather to provide learners with information from which they may make their own judgments. Informed learners are the final safeguards in assuring that a CME activity is independent from commercial influence.
AACE has reviewed all disclosures and resolved or managed all identified conflicts of interest for this educational activity, as applicable.
Developed through a partnership between Medscape and the American Association of Clinical Endocrinologists (AACE).
The American Association of Clinical Endocrinologists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Association of Clinical Endocrinologists (AACE) designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For questions regarding this CME activity, please contact:
AACE CME Department
Phone: (904) 353-7878
Contact this provider
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
- 1.00 AMA PRA Category 1 Credit™
This course is offered through Medscape. To take this course you will be redirected to Medscape's website. You must have an account with Medscape in order to complete this activity.
MOCINGBIRD continues to work with our CME partner network to provide courses directly to you. We appreciate your patience as we work toward that goal!